Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GLB1L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRC5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LINC00299 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NLRP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRSS23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARVA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADD3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CA5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NALT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAT1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COL5A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTATIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on